Company intelligence / Profile preview

GSK Vaccines Global Health

London, England, United Kingdom

Ownership: Private
Employees: ~65000
Development stage: Other

Overview

GSK has the broadest pipeline of innovative vaccines globally, with vaccines against 23 of 32 WHO-identified preventable diseases, and a leading clinical portfolio (including the world’s first approved malaria vaccine, RTS,S, for children) targeting high-burden infectious diseases in resource-limited settings[2][3][4][6][8].

Therapeutic areas: Infectious Diseases
Modalities: VaccineBiologicmRNA-based drugsRecombinant proteinAdjuvant
Industry: Pharma

Partnerships

PATH (malaria vaccine)Bill & Melinda Gates Foundation (malaria and other global health initiatives)Sanofi (COVID-19 vaccines)[3]Pfizer (ViiV Healthcare for HIV drugs)[3][4]Shionogi (ViiV Healthcare for HIV drugs)[4]

Beyond the preview

Go deeper on GSK Vaccines Global Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GSK Vaccines Global Health.

Explore the full profile